ADAMA Ltd. is a global leader in crop protection, specializing in the manufacturing and retailing of herbicides, insecticides, fungicides, plant growth regulators, seed treatments, and biosolutions. The company is headquartered in Ashdod, Israel, and operates worldwide, with research and development, chemical synthesis, and formulation facilities located in various countries including China, India, Brazil, and across Europe and North America.
Founded in 1945, ADAMA has evolved through mergers and acquisitions, becoming a prominent player in the agricultural sector. The company offers a diverse portfolio with over 300 active ingredients and more than 1,000 end-use products designed for major crops such as soybean, corn, and cotton. ADAMA focuses on farmer-centric innovation, leveraging proprietary technologies and partnerships to optimize crop yields while minimizing health and environmental impacts. With a presence in over 100 countries and a workforce of more than 8,500 employees, ADAMA is committed to supporting farmers and growers globally.
Manufacturer of agricultural products intended to help farmers around the world grow crops while using energy, water, and land more efficiently. The company offers seeds, advanced traits, software, and crop protection products, thereby helping fameres improve yield and efficiency.
Marrone Bio Innovations Inc is a US-based agricultural company engaged in the discovery, development and sale of innovative biological products for crop protection, crop health and crop nutrition. The company produces bio-based pest management and plant health products such as Biopesticides, Bioinsecticides, Bionematicides, Biofungicides, Biostimulants and Bionutrition, among others. It generates key revenue from the sales of Marrone products, mainly Regalia, Grandevo and Venerate.
Operator of a contract manufacturing organization (CMO) focused on providing advanced pharmaceutical technologies, contract development and commercial manufacturing services to biopharmaceutical companies. The company's technology platforms offer taste masking, controlled release, solubility enhancement and patient-centric dosing solutions that facilitate the commercialization of safe pharmaceutical products, helping clients to develop novel, enhanced medicines and therapies for the global market.